The Cancer Research Institute is inviting academic researchers to apply for the CRI Clinical Innovator program, which funds investigator-initiated immunotherapy clinical trials aimed at advancing novel cancer treatments and deepening understanding of immune mechanisms in oncology. The CRI Clinical Innovator program was established to support pioneering clinical trials in immunotherapy, aiming to transform patient care
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: